Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.

Maurer BJ, Kalous O, Yesair DW, Wu X, Janeba J, Maldonado V, Khankaldyyan V, Frgala T, Sun BC, McKee RT, Burgess SW, Shaw WA, Reynolds CP.

Clin Cancer Res. 2007 May 15;13(10):3079-86.

2.

Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis.

Lepage G, Yesair DW, Ronco N, Champagne J, Bureau N, Chemtob S, Bérubé D, Roy CC.

J Pediatr. 2002 Aug;141(2):178-85.

PMID:
12183711
3.

Development, evaluation and use of a pharmacokinetic model for hexachlorobenzene.

Yesair DW, Feder PI, Chin AE, Naber SJ, Kuiper-Goodman T, Scott CS, Robinson PE.

IARC Sci Publ. 1986;(77):297-318.

PMID:
3596717
4.

Human disposition and some biochemical aspects of methylxanthines.

Yesair DW, Branfman AR, Callahan MM.

Prog Clin Biol Res. 1984;158:215-33. Review.

PMID:
6396646
5.

Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine.

Callahan MM, Robertson RS, Branfman AR, McComish MF, Yesair DW.

Drug Metab Dispos. 1983 May-Jun;11(3):211-7. No abstract available.

PMID:
6135578
6.

Characterization of diaminouracil metabolites of caffeine in human urine.

Branfman AR, McComish MF, Bruni RJ, Callahan MM, Robertson R, Yesair DW.

Drug Metab Dispos. 1983 May-Jun;11(3):206-10.

PMID:
6135577
7.

Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.

Callahan MM, Robertson RS, Arnaud MJ, Branfman AR, McComish MF, Yesair DW.

Drug Metab Dispos. 1982 Jul-Aug;10(4):417-23.

PMID:
6126344
8.

Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.

Chadwick M, Silveira DM, MacGregor JA, Branfman AR, Liss RH, Yesair DW.

Cancer Res. 1982 Feb;42(2):627-32.

9.

Pharmacological implications of the interaction of heavy metals with novel macromolecular lipids.

Yesair DW, Taylor RF.

Drug Metab Rev. 1982;13(3):517-33. No abstract available.

PMID:
7105973
10.

Drug-binding macromolecular lipids from L1210 leukemia tumors.

Taylor RF, Teague LA, Yesair DW.

Cancer Res. 1981 Nov;41(11 Pt 1):4316-23. No abstract available.

11.

Comparison of the metabolism in dogs of estradiol-17 beta following its intravenous and oral administration.

Longcope C, Yesair DW, Williams KI, Callahan MM, Bourget C, Brown SK, Carraher MS, Flood C, Rachwall PC.

J Steroid Biochem. 1980 Sep;13(9):1047-55. No abstract available.

PMID:
7421245
12.

Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo.

Yesair DW, Thayer PS, McNitt S, Teague K.

Eur J Cancer. 1980 Jul;16(7):901-7. No abstract available.

PMID:
7428784
13.

Characterization of the urinary metabolites of 5-azacytidine in mice.

Kelly CJ, Coles E, Gaudio L, Yesair DW.

Biochem Pharmacol. 1980 Feb 15;29(4):609-15. No abstract available.

PMID:
6154465
14.
15.

Binding of the Cain quinolinium, NSC 113089, to rat tissue lipid extracts.

Yesair DW, Callahan M, McComish MF, Taylor RF.

Cancer Biochem Biophys. 1979;3(4):163-8.

PMID:
552904
16.

Characterization of the metabolites of ellipticine in rat bile.

Branfman AR, Bruni RJ, Reinhold VN, Silveira DM, Chadwick M, Yesair DW.

Drug Metab Dispos. 1978 Sep-Oct;6(5):542-8.

PMID:
30603
17.

Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.

Kelly CJ, Gaudio L, Yesair DW, Schoenemann PT, Wodinsky I.

Cancer Treat Rep. 1978 Jul;62(7):1025-32.

PMID:
80268
18.

Importance of schedule in adriamycin/cyclophosphamide combination chemotherapy.

Yesair DW, McNitt S, Tobias J, Wodinsky I.

Eur J Cancer. 1978 Feb;14(2):141-6. No abstract available.

PMID:
624311
19.

Pharmacokinetic consequences of plasma protein binding of drugs.

Schoenemann PT, Yesair DW, Coffey JJ, Bullock FJ.

Ann N Y Acad Sci. 1973 Nov 26;226:162-71. No abstract available.

PMID:
4520393
20.

Daunomycin and adriamycin metabolism via reductive glycosidic cleavage.

Asbell MA, Schwartzbach E, Bullock FJ, Yesair DW.

J Pharmacol Exp Ther. 1972 Jul;182(1):63-9. No abstract available.

PMID:
5041655
21.

Metabolism of daunomycin (NSC-82151) in vitro and the chemotherapeutic activity of isolated metabolites in vivo.

Asbell MA, Schwartzbach E, Wodinsky I, Yesair DW.

Cancer Chemother Rep. 1972 Jun;56(3):315-20.

PMID:
19051489
22.

Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.

Yesair DW, Schwartzbach E, Shuck D, Denine EP, Asbell MA.

Cancer Res. 1972 Jun;32(6):1177-83. No abstract available.

23.

Comparative studies of drug uptake, viability, and biosynthetic capabilities of P388 cells treated with "active" or "inactive" terephthalanilides.

Yesair DW, Thayer PS, Kensler CJ.

Ann N Y Acad Sci. 1971 Jul 23;172(18):655-65. No abstract available.

PMID:
5286477
24.

Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys.

Yesair DW, Callahan M, Remington L, Kensler CJ.

Biochem Pharmacol. 1970 May;19(5):1579-90. No abstract available.

PMID:
5535185
25.

Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats.

Yesair DW, Remington L, Callahan M, Kensler CJ.

Biochem Pharmacol. 1970 May;19(5):1591-600. No abstract available.

PMID:
5513943
26.

Method for extraction and separation of drugs and metabolites from biological tissue.

Yesair DW, Coutinho CB.

Biochem Pharmacol. 1970 May;19(5):1569-78. No abstract available.

PMID:
5513942
27.

Potential alloxan-diabetic compounds from the reaction of alloxan, glutathione and nitrogen bases.

Yesair DW.

Biochem Pharmacol. 1970 Mar;19(3):687-95. No abstract available.

PMID:
5537353
28.

Hydrolysis of conjugated bile acids by cell-free extracts from aerobic bacteria.

Yesair DW, Himmelfarb P.

Appl Microbiol. 1970 Feb;19(2):295-300.

29.
30.

Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells.

Yesair DW, Rogers WI, Baronowsky PE, Wodinsky I, Thayer PS, Kensler CJ.

Cancer Res. 1967 Feb;27(2):314-21. No abstract available.

31.

Purification and characterization of phthalanilide--lipid complexes from tissues.

Yesair DW, Rogers WI, Funkhouser JT, Kensler CJ.

J Lipid Res. 1966 Jul;7(4):492-500.

33.
34.

Toxicology of anti-leukemic agents with special reference to phthalanilide derivatives.

Kensler CJ, Palm PE, Day HM, Battista SP, Rogers WI, Yesair DW, Wodinsky I.

Cancer Res. 1965 Oct;25(9):1622-37. No abstract available.

35.

Cholesterol in vitamin B12-deficient chick embryo.

DANIEL LJ, COHEN S, YESAIR DW.

Proc Soc Exp Biol Med. 1961 Oct;108:119-21. No abstract available.

PMID:
13883387
36.

Vitamin B12 in developing chick embryos from vitamin B12-deficient and control eggs.

DANIEL LJ, HILARY CA, YESAIR DW.

Arch Biochem Biophys. 1960 Oct;90:250-3. No abstract available.

PMID:
13719601
37.

The effect of vitamin B12 on the blood serum protein and lipoprotein in the developing chick embryo.

YESAIR DW, GOLDSTEIN J, DANIEL LJ.

Arch Biochem Biophys. 1959 Oct;84:316-23. No abstract available.

PMID:
13846523
38.

The role of the reducing agent in the activation of aconitase.

HERR EB Jr, SUMNER JB, YESAIR DW.

Biochim Biophys Acta. 1956 May;20(2):310-4. No abstract available.

PMID:
13328854
39.

A study of the kinetics of aconitase inhibition and activation.

HERR EB Jr, SUMNER JB, YESAIR DW.

Arch Biochem Biophys. 1956 May;62(1):29-39. No abstract available.

PMID:
13314635

Supplemental Content

Loading ...
Support Center